Daily Newsletter

29 August 2023

Daily Newsletter

29 August 2023

GE HealthCare launches new wireless ultrasound imaging system

The system helps clinicians view clear cardiac and vascular images at the point of care.

RanjithKumar Dharma August 28 2023

GE HealthCare has rolled out the new handheld, wireless ultrasound imaging system, Vscan Air SL, for rapid assessments of cardiac and vascular patients.

Part of the Vscan product suite, the new system features SignalMax and XDclear technology, facilitating better resolution, penetration, and sensitivity in imaging performance using single-crystal transducer technology.

Clinicians can use the system for viewing clear cardiac and vascular images at the point of care. It also helps them streamline workflows and eliminate overloading traditional radiology resources.

With Vscan Air + Digital Tools, healthcare professionals can utilise subscriptions that link them to a range of user-friendly solutions intended to enhance workflow.          

GE HealthCare Point Of Care and Handheld Ultrasound global general manager Dietmar Seifriedsberger said:Vscan Air SL enables clinicians to make quick cardiac assessments and adds to our broad portfolio of ultrasound technologies to help further inform clinical decision making at the point of care.

“This newest innovation demonstrates our commitment to providing integrated solutions resulting in better standard of care delivery — and ultimately helping clinicians improve patient outcomes.”

The Vscan Air SL is presently available for purchase in countries across Europe, Asia, Australia, and New Zealand.

In the US, the device has received 510(k) clearance from the US Food and Drug Administration. It is set to be released for commercial use in the current quarter.

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close